- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01660516
Effect of Tea on Endothelial Function and Ischaemia-reperfusion Injury
Effect of Black Tea Consumption on Endothelial Function and Ischaemia-reperfusion Injury in Humans
Tea consumption may impact upon the decrease in endothelial function after IR-injury. However, no previous study directly examined the potential of tea to impact upon the change in endothelial function after IR-injury.
The investigators hypothesize that tea consumption counteracts endothelial damage in response to ischaemia reperfusion injury in healthy humans.
Study Overview
Status
Conditions
Detailed Description
Rationale: Occlusion of an artery (causing ischemia) is a frequently reported condition, e.g. myocardial infarction, cerebral infarction or during organ transplantations. The period of ischemia will be followed by reperfusion (possibly after an operation). The ischaemic period as well as the reperfusion are both associated with damage to the tissue, including the endothelium. It is hypothesised that production of oxidative stress and reduced NO bioactivity (through increased reactive oxygen production) during ischaemia and reperfusion is involved in the development of tissue damage to the endothelium. Interventions that can prevent or attenuate endothelial dysfunction in response to ischemia-reperfusion (IR)-injury have a potential clinical relevance to prevent (complications of) cardiovascular disease.
Several studies have examined the effect of tea consumption on the endothelial function. These studies demonstrated a dose-dependent improvement of tea to improve endothelial function in healthy and diseased humans, possibly through the vasoactive effects of flavonoids, which may involve increased nitric oxide bioactivity and inhibition of NADPH oxidase. Based on the ability of flavonoids to decrease (the impact of) oxidative stress, tea consumption may also impact upon the decrease in endothelial function after IR-injury. However, no previous study directly examined the potential of tea to impact upon the change in endothelial function after IR-injury.
Objective: To examine whether tea consumption counteracts endothelial damage in response to ischaemia reperfusion injury in healthy humans.
Main study parameters: Change in endothelial function (measured with flow mediated dilation) after ischaemia reperfusion injury (induced by 20 minutes ischemia and 20 min reperfusion) with and without precedence of tea consumption.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Non-invasive cuff occlusion is used to examine endothelial function (5-minute ischaemia) and produce the stimulus that induces ischaemia-reperfusion injury (20-minute ischaemia). This repeated cuff inflation is non-invasive and not associated with a health risk for the subject. Tea consumption is safe and, most likely, daily routine for most participants. The only difference is that this study will monitor and instruct participants regarding their tea consumption in the week preceding the tests. The volunteers will not benefit directly from participating in this study.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Gelderland
-
Nijmegen, Gelderland, Netherlands, 6525 EX
- Radboud University Nijmegen Medical Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Healthy volunteers : age 18-60
- All subjects: written informed consent
Exclusion Criteria:
- Smoking
- History of any cardiovascular disease
- Hypertension (in supine position: systole >140 mmHg, diastole >90 mmHg)
- Diabetes Mellitus
- Hyperlipidaemia (fasting total cholesterol >6.5 mmol/L)
- Chronic use of medication known to interfere with the cardiovascular system
- Professional athletes
- Alcohol consumption >14 units/week
- BMI >30 kg/m2
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Tea
Black tea ingestion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Endothelial Function after ischaemia reperfusion injury
Time Frame: three weeks
|
Change in endothelial function (measured with flow mediated dilation) after ischaemia reperfusion injury (induced by 20 minutes ischemia and 20 min reperfusion) with and without precedence of tea consumption
|
three weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in baseline flow mediated dilation after water/tea consumption
Time Frame: three weeks
|
Change in baseline flow mediated dilation after water/tea consumption
|
three weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Dick Thijssen, Dr., Radboud University Medical Centre Nijmegen
- Principal Investigator: Maria Hopman, prof. dr., Radboud University Medical Center
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TEA-IRI
- Tea-IR-Injury-FMD (OTHER: Radboud University Nijmegen Medical Centre)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ischaemia Reperfusion Injury
-
University of AarhusErasmus Medical Center; Fonden til Lægevidenskabens FremmeCompletedIschemia Reperfusion Injury | Ischaemia Reperfusion InjuryDenmark
-
Queen Mary University of LondonUniversity College, LondonWithdrawnIschaemia-reperfusion (IR) InjuryUnited Kingdom
-
University Hospital, Strasbourg, FranceUnknownIschaemia-reperfusion InjuryFrance
-
Papa Giovanni XXIII HospitalRecruitingLiver Transplantation | Early Allograft Dysfunction | Post-Reperfusion Syndrome | Ischaemia-Reperfusion InjuryItaly
-
The Hospital for Sick ChildrenUnknownComplication of Anesthesia | Ischaemia-reperfusion InjuryCanada
-
University of OxfordCompletedAtrial Fibrillation | Disorder; Heart, Functional, Postoperative, Cardiac Surgery | Ischaemia-reperfusion Injury | Cardiac Insufficiency Following Cardiac SurgeryUnited Kingdom
-
Xijing HospitalCompletedEnd Stage Liver Disease | Liver Failure | Postoperative Complications | Fatty Liver | Liver Transplant; Complications | Ischaemia Reperfusion Injury of LiverChina
-
University of AarhusCompletedReperfusion Injuries, Myocardial
-
University of ChileFondo Nacional de Desarrollo Científico y Tecnológico, ChileCompletedReperfusion Injury | Acute Myocardial Infarction | Ischemia-reperfusion Injury | Reperfusion Injury, Myocardial | Reperfusion ArrhythmiasChile
-
Chinese PLA General HospitalUnknown